Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phio Pharmaceuticals (PHIO) Amortizatization of Intangibles (2019 - 2021)

Phio Pharmaceuticals' Amortizatization of Intangibles history spans 6 years, with the latest figure at $30000.0 for Q4 2021.

  • For Q4 2021, Amortizatization of Intangibles rose 7.14% year-over-year to $30000.0; the TTM value through Dec 2021 reached $117000.0, up 5.41%, while the annual FY2024 figure was $33000.0, 74.22% down from the prior year.
  • Amortizatization of Intangibles reached $30000.0 in Q4 2021 per PHIO's latest filing, up from $29000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $30000.0 in Q4 2021 to a low of $27000.0 in Q2 2019.
  • Average Amortizatization of Intangibles over 3 years is $28083.3, with a median of $28000.0 recorded in 2019.
  • Peak YoY movement for Amortizatization of Intangibles: dropped 3.57% in 2020, then increased 7.41% in 2021.
  • A 3-year view of Amortizatization of Intangibles shows it stood at $27000.0 in 2019, then grew by 3.7% to $28000.0 in 2020, then grew by 7.14% to $30000.0 in 2021.
  • Per Business Quant, the three most recent readings for PHIO's Amortizatization of Intangibles are $30000.0 (Q4 2021), $29000.0 (Q3 2021), and $29000.0 (Q2 2021).